The 5th Madina Annual Rare Disease Congress is a premier platform bringing together healthcare professionals, researchers, and industry leaders dedicated to improving the diagnosis, treatment, and long-term care of patients living with rare and genetic disorders.
Hosted by King Salman bin Abdulaziz Medical City in partnership with Boshra and SSMG, this one-day scientific gathering will feature a rich agenda designed to foster collaboration, clinical knowledge sharing, and innovation.
This year's congress will focus on bridging the gap between research and real-world practice — empowering physicians with practical strategies, emerging therapies, and breakthrough diagnostic tools that make a meaningful difference in patient lives.
The 5th edition reinforces the congress as a leading regional platform advancing scientific collaboration, innovation, precision medicine, and comprehensive rare disease care across multiple specialties.
Advance your clinical knowledge through expert-led sessions on rare, genetic, neurological, and metabolic disorders, delivered by renowned regional and international speakers.
Stay at the forefront of rare disease research and innovation, exploring the latest in gene therapy, biologics, precision medicine, and cutting-edge diagnostics.
Discover real-world case studies and solutions that address both pediatric and adult presentations of rare diseases.
Participate in interactive workshops and symposia, designed to deepen practical understanding and foster hands-on learning.
Engage in high-level networking with specialists across genetics, neurology, internal medicine and other key disciplines.
Collaborate with key stakeholders, including hospitals, policymakers, industry leaders, and advocacy groups working to advance rare disease care.
Promote awareness and community support through educational activities tailored to underserved patient populations.
Be part of a mission-driven platform that empowers early diagnosis, enhances patient outcomes, and drives impactful change in healthcare systems.
Expert-led sessions covering a wide spectrum of rare and genetic diseases, including metabolic, neurological, and skeletal disorders.
Focus on gene therapy, disease-modifying treatments, and precision diagnostics driven by genomics and biomarkers.
Dedicated sessions exploring adult presentations of rare diseases — an evolving and often under-addressed field in clinical practice.
Innovative symposia hosted by leading pharmaceutical companies, highlighting the latest therapeutic advancements.
Opportunities for poster presentations and clinical case discussions, fostering exchange of research findings and clinical experiences.
A strong focus on multidisciplinary care models and patient-centered approaches to improve outcomes and support underserved communities.
Networking breaks and cultural engagement moments that promote meaningful collaboration, peer-to-peer learning, and regional knowledge exchange.
Participants will earn Continuing Medical Education (CME) hours upon attending the full scientific program. Accredited sessions will support physicians and healthcare professionals in fulfilling their professional development requirements and staying current with the latest advances in rare disease care.